How to De-risk the Development of Highly Sensitive Injectables Using High-Performance Pre-fillable Syringe Systems

Author(s):

Enrico Barichello, Product Manager for the Syringe Platform at Stevanato Group, discusses the risks associated with the interaction between primary packaging and complex novel therapeutics and describes how to prevent or manage concerns utilizing newer, pre-sterilized syringe systems that have more unique characteristics.

LEARN MORE IN THIS VIDEO:

How Stevanato Group has responded to challenges pertaining to primary packaging of complex highly sensitive injectables
Concerns with silicone and biopharmaceutical development
Features of ALBA^® technology for high-performance pre-fillable syringe systems

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!